Literature DB >> 6888852

Immunologic defense mechanisms of the ocular surface.

J W Chandler, T E Gillette.   

Abstract

The ocular surface represents an immunologic microcosm in which certain local immunologic and paraimmunologic defense systems analogous or identical to those of other mucosal surfaces are operative. These defenses include a resident normal flora; intrinsic anatomic barriers; secretion of mucous and certain chemical bacteriostatics and bacteriolytics; local humoral (slgA) antibody secretion; and local T-lymphocyte cellular responses. A series of sophisticated mechanisms has evolved to defend the ocular surface against diverse environmental pathogens. Often, the activation of one system leads to the subsequent activation of another, providing a highly integrated, series of mechanisms for host defense. And, it is clear that close integration of these various mechanisms provides a highly efficient amplification system for host defense, so that when one mechanism fails to deal with the invading pathogen the next mechanism is then efficiently initiated. Only in those situations where the pathogen overwhelms these defense systems, or is of such a persistent nature that it becomes resistant to removal by these various mechanisms, or alternatively is able to subvert its identity and, therefore, evade these mechanisms do organisms infect and cause disease. It is undoubtedly the complex interaction of all of these defense systems, both paraimmunologic and immunologic, which finally determines the integrity of the ocular surface.

Mesh:

Substances:

Year:  1983        PMID: 6888852     DOI: 10.1016/s0161-6420(83)34510-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Development of organised conjunctival leucocyte aggregates after corneal transplantation in rats.

Authors:  S Banerjee; F C Figueiredo; D L Easty; A D Dick; S M Nicholls
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

2.  Bacterial infection in scarring trachoma.

Authors:  Victor H Hu; Patrick Massae; Helen A Weiss; Caroline Chevallier; Jecinta J Onyango; Isaac A Afwamba; David C W Mabey; Robin L Bailey; Matthew J Burton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

Review 3.  The role of eye-associated lymphoid tissue in corneal immune protection.

Authors:  Erich Knop; Nadja Knop
Journal:  J Anat       Date:  2005-03       Impact factor: 2.610

Review 4.  Aging and the lacrimal system.

Authors:  N J Van Haeringen
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

5.  Regional differences in rat conjunctival ion transport activities.

Authors:  Dongfang Yu; William R Thelin; Troy D Rogers; M Jackson Stutts; Scott H Randell; Barbara R Grubb; Richard C Boucher
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-18       Impact factor: 4.249

6.  Bacterial and fungal flora in healthy eyes of birds of prey.

Authors:  C Dupont; M Carrier; R Higgins
Journal:  Can Vet J       Date:  1994-11       Impact factor: 1.008

7.  Loss of NHE8 expression impairs ocular surface function in mice.

Authors:  Hua Xu; Yang Zhao; Jing Li; Mingwu Wang; Fangru Lian; Minghong Gao; Fayez K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2014-11-05       Impact factor: 4.249

8.  Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.

Authors:  J A P Gomes; H S Dua; L V Rizzo; M Nishi; A Joseph; L A Donoso
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

9.  Phenotypes of conjunctival inflammatory cells in sarcoidosis.

Authors:  A Karma; E Taskinen; H Kainulainen; M Partanen
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

10.  M cells are involved in pathogenesis of human contact lens-associated giant papillary conjunctivitis.

Authors:  Xingwu Zhong; Hongshan Liu; Aijun Pu; Xuefeng Xia; Xiaodong Zhou
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-06-08       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.